Исследования
Образование
Решения
RU
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
AR - العربية
Войдите в систему
Nanotechnology Characterization Lab.,
Cancer Research Technology Program,
Nanotechnology Characterization Lab., Cancer Research Technology Program
Marina A. Dobrovolskaia has not added Biography.
If you are Marina A. Dobrovolskaia and would like to personalize this page please email our Author Liaison for assistance.
Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro.
Molecules (Basel, Switzerland) Jul, 2018 | Pubmed ID: 30002298
Animal models for analysis of immunological responses to nanomaterials: Challenges and considerations.
Advanced drug delivery reviews Nov - Dec, 2018 | Pubmed ID: 30273617
Roadmap and strategy for overcoming infusion reactions to nanomedicines.
Nature nanotechnology Dec, 2018 | Pubmed ID: 30348955
Frederick National Laboratory for Cancer Research sponsored by National Cancer Institute
Barry W. Neun1,
Marina A. Dobrovolskaia1
1Nanotechnology Characterization Lab., Cancer Research Technology Program, Frederick National Laboratory for Cancer Research sponsored by National Cancer Institute
Конфиденциальность
Условия эксплуатации
Политика
СВЯЖИТЕСЬ С НАМИ
РЕКОМЕНДОВАТЬ БИБЛИОТЕКЕ
НОВОСТИ JoVE
JoVE Journal
Подборки методов
JoVE Encyclopedia of Experiments
Архив
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
АВТОРЫ
Библиотекарь
Доступ
О JoVE
JoVE Sitemap
Авторские права © 2025 MyJoVE Corporation. Все права защищены